Abstract:Klebsiella pneumoniae (K. pneumoniae), a kind of zoonotic bacteria, is among the most common antibiotic-resistant pathogens, and it causes nosocomial infections that pose a threat to public health. In this study, the roles of synthetic bovine neutrophil β-defensin-5 (B5) in regulating inflammatory response and metabolic response against multidrug-resistant K. pneumoniae infection in a mouse model were investigated. Mice were administrated intranasally with 20 μg of B5 twice and challenged with K. pneumoniae three days after B5 pretreatment. Results showed that B5 failed to directly kill K. pneumoniae in vitro, but it provided effective protection against multidrug-resistant K. pneumoniae via decreasing the bacterial load in the lungs and spleen, and by alleviating K. pneumoniae-induced histopathological damage in the lungs. Furthermore, B5 significantly enhanced the mRNA expression of TNF-α, IL-1β, Cxcl1, Cxcl5, Ccl17, and Ccl22 and obviously enhanced the rapid recruitment of macrophages and dendritic cells in the lungs in the early infection phase, but significantly down-regulated the levels of TNF-α, IL-1β, and IL-17 in the lungs in the later infection phase. Moreover, RNA-seq results showed that K. pneumoniae infection activated signaling pathways related to natural killer cell-mediated cytotoxicity, IL-17 signaling pathway, inflammatory response, apoptosis, and necroptosis in the lungs, while B5 inhibited these signaling pathways. Additionally, K. pneumoniae challenge led to the suppression of glycerophospholipid metabolism, the phosphotransferase system, the activation of microbial metabolism in diverse environments, and metabolic pathways in the lungs. However, B5 significantly reversed these metabolic responses. Collectively, B5 can effectively regulate the inflammatory response caused by K. pneumoniae and offer protection against K. pneumoniae. B5 may be applied as an adjuvant to the existing antimicrobial therapy to control multidrug-resistant K. pneumoniae infection. Our study highlights the potential of B5 in enhancing pulmonary bacterial clearance and alleviating K. pneumoniae-caused inflammatory damage.

Immunoregulatory and Antimicrobial Activity of Bovine Neutrophil -Defensin-5-Loaded PLGA Nanoparticles against <i>Mycobacterium bovis</i>

Recombinant ArgF PLGA nanoparticles enhances BCG induced immune responses against <i>Mycobacterium</i> <i>bovis</i> infection

Recombinant ArgF PLGA nanoparticles enhances BCG induced immune responses against Mycobacterium bovis infection

CFP10–loaded PLGA Nanoparticles As a Booster Vaccine Confer Protective Immunity Against Mycobacterium Bovis

Antimycobacterial Activity of Pichia Pastoris-Derived Mature Bovine Neutrophil Β-Defensins 5.

Intranasal Bovine Β-Defensin-5 Enhances Antituberculosis Immunity in a Mouse Model by a Novel Protein-Based Respiratory Mucosal Vaccine

Antimicrobial Activity of Recombinant Mature Bovine Neutrophil Β-Defensin 4 on Mycobacterial Infection.

Bovine Neutrophil β-Defensin-5 Provides Protection against Multidrug-Resistant Klebsiella pneumoniae via Regulating Pulmonary Inflammatory Response and Metabolic Response

Intracellular Activity of Poly (DL-Lactide-co-Glycolide) Nanoparticles Encapsulated with Prothionamide, Pyrazinamide, Levofloxacin, Linezolid, or Ethambutol on Multidrug-Resistant Mycobacterium tuberculosis

Bfra-loaded Nanoparticles Confer Protection Against Paratuberculosis Infection

Lipids Extracted from Mycobacterial Membrane and Enveloped PLGA Nanoparticles for Encapsulating Antibacterial Drugs Elicit Synergistic Antimicrobial Response against Mycobacteria

Intranasal B5 promotes mucosal defence against Actinobacillus pleuropneumoniae via ameliorating early immunosuppression

Mycobacterium Bovis BCG Surface Antigens Expressed under the Granuloma-Like Conditions As Potential Inducers of the Protective Immunity.

An immunoregulator nanomedicine approach for the treatment of tuberculosis

A novel DNA vaccine for protective immunity against virulent Mycobacterium bovis in mice

A New Poly(i:C)-Decorated PLGA-PEG Nanoparticle Promotes Mycobacterium Tuberculosis Fusion Protein to Induce Comprehensive Immune Responses in Mice Intranasally.

Investigation of the Effect of Mycobacterium Bovis Infection on Bovine Neutrophils Functions

Antimicrobial activity of bovine NK-lysin-derived peptides on Mycoplasma bovis

Influences of Surface Coating of PLGA Nanoparticles on Immune Activation of Macrophages.

Multicomponent Pathogen-Mimicking Nanoparticles Induce Intestinal Immune Responses against Paratuberculosis

Evaluation of PLGA, lipid-PLGA hybrid nanoparticles, and cationic pH-sensitive liposomes as tuberculosis vaccine delivery systems in a Mycobacterium tuberculosis challenge mouse model - A comparison